Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 17Unknown 12Recruiting 7Not yet recruiting 4Terminated 3Suspended 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Pancreatic Neoplasms 9Carcinoma, Non-Small-Cell Lung 7Rectal Neoplasms 6Colorectal Neoplasms 6Breast Neoplasms 6Neoplasms 5Glioblastoma 5Squamous Cell Carcinoma of Head and Neck 4Ovarian Neoplasms 4Head and Neck Neoplasms 4Stomach Neoplasms 3Oligodendroglioma 3Mouth Neoplasms 3Lung Neoplasms 3Glioma 3Esophageal Neoplasms 3Astrocytoma 3Urinary Bladder Neoplasms 2Sarcoma 2Neoplasm Metastasis 2Meningioma 2Melanoma 2Gliosarcoma 2Glioma, Subependymal 2Fallopian Tube Neoplasms 2Ependymoma 2Carcinoma, Squamous Cell 2Carcinoma, Ovarian Epithelial 2Adenocarcinoma Of Esophagus 2Xerostomia 1

Interventions

Capecitabine 27pembrolizumab 19Oxaliplatin 19Fluorouracil 17Cisplatin 17Trastuzumab 14Docetaxel 14Leucovorin 11Paclitaxel 8Irinotecan 8S 1 (combination) 7Epirubicin 6Cyclophosphamide 5tegafur-gimeracil-oteracil 4aldesleukin 4Hyperthermic Intraperitoneal Chemotherapy 4titanium silicide 3spartalizumab 3fludarabine phosphate 3fludarabine 3Surveys and Questionnaires 3Surgical Procedures, Operative 3Ramucirumab 3Nivolumab 3Indocyanine Green 3Gemcitabine 3Carboplatin 3Albumin-Bound Paclitaxel 3Ado-Trastuzumab Emtansine 3vistusertib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Stomach Neoplasms × Surgical Procedures, Operative × Clear all
NCT03042169 2025-12-23

SURGIGAST

University Hospital, Lille

Phase 3 Terminated
6 enrolled
Gastrointestinal

Stomach Neoplasms

NCT02485834 2025-01-20

FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Terminated
5 enrolled 11 charts
Gastrointestinal

Stomach Neoplasms

NCT00848783 2018-01-08

Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers

NYU Langone Health

Phase 2 Terminated
8 enrolled 9 charts
Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡